UCLA study finds pre-surgery immunotherapy safe for pancreatic cancer patients

FHS
April 6, 2024
3:51 am

A pilot study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that for people with borderline resectable pancreatic cancer, administrating an immunotherapy drug in combination with chemotherapy before surgery is safe and may improve long-term outcomes.

Illumina’s chief commercial officer to leave, marking another executive departure

Susan Tousi, Illumina’s chief commercial officer, is slated to leave the company in the latest executive shakeup after a CEO change last year. Named chief

January 5, 2024

Pα+ Psychedelic Bulletin #173: Upcoming Trial Readouts to Watch; Lykos Prioritises Preparing for Resubmission Over Formal Dispute – Psychedelic Alpha

In this Issue Upcoming Trial Readouts to Watch Lykos Prioritises Preparing for Resubmission Over Formal Dispute Bogenschutz Scores $3.8m NIAAA Grant for Psilocybin in Alcohol

September 21, 2024

Cadaveric pituitary-derived growth hormone delivery influences iatrogenic Alzheimer’s Disease

Recipients of cadaver-derived pituitary growth hormone (c-hGH) developed biomarker changes in the realm of Alzheimer’s disease (AD).

January 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.